Pharos iBio Co. utilizes its AI-driven Chemiverse® platform to develop targeted therapies for rare and intractable diseases by analyzing protein structures and leveraging big data. The company aims to provide effective treatment options for patients suffering from conditions that currently lack viable solutions.
Funding
Funding not disclosed
Founders
Product
Problem
Many rare and intractable diseases lack effective treatment options, leaving patients with limited or no viable solutions. Traditional drug discovery methods often struggle to identify promising drug candidates for these conditions due to the complexity of protein structures and the limited availability of relevant data.
Solution
Pharos iBio utilizes its proprietary AI-driven Chemiverse® platform to accelerate the development of targeted therapies for rare and intractable diseases. The platform analyzes protein structures and leverages big data to identify promising drug candidates and predict their efficacy. By integrating AI and big data analytics, Pharos iBio aims to provide effective treatment options for patients suffering from conditions that currently lack viable solutions, thereby addressing unmet medical needs. The Chemiverse® platform encompasses nine modules applicable from target identification to preclinical stages.
Target Audience
The primary target audience includes patients suffering from rare and intractable diseases, as well as pharmaceutical companies and research institutions seeking to develop novel therapies for these conditions.
Features
- AI-driven drug discovery platform for identifying and optimizing drug candidates
- Chemiverse® platform analyzes protein structures and leverages big data
- Target identification module for selecting the most promising therapeutic targets
- Preclinical development module for evaluating drug efficacy and safety
- Big data analytics capabilities for identifying patterns and insights from complex datasets
- AI algorithms for predicting drug-target interactions and optimizing drug design
- Open innovation approach to expand human and physical resources